Interview with Dr. Keith Wailoo on the medical and social context that has made progress in treating sickle cell disease slow and arduous. (11:31)Download Given sickle cell disease’s prevalence among black Americans, questions of race and stigma have shadowed the history of its medical treatment. Recent developments in treating pain crises and gene therapy are part of a history of slow progress tinged with constant peril.
No takes yet. Share an insight, caveat, or question.
Keith Wailoo (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: